Quarterly Report · 10-Q
AngioDynamics, Inc.
ANGONASDAQEQUITYCurrent
Quarterly Report
Company context
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients. The Company’s innov ative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security HoldersNov 18, 2026
- SCHEDULE 13G/A - filed by Point72 Asset Management, L.P. regarding ANGIODYNAMICS INCNov 16, 2026
- 10-Q filingOct 8, 2026
- DEFA14A filingOct 8, 2026
- DEF 14A filingOct 8, 2026
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗